Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 62% ± 24% | |
retinal rod cell | 9 studies | 54% ± 23% | |
GABAergic neuron | 7 studies | 52% ± 23% | |
retinal cone cell | 6 studies | 62% ± 12% | |
adipocyte | 6 studies | 31% ± 8% | |
oligodendrocyte precursor cell | 5 studies | 29% ± 10% | |
neuron | 4 studies | 30% ± 6% | |
endothelial cell | 4 studies | 31% ± 11% | |
retinal bipolar neuron | 4 studies | 28% ± 4% | |
interneuron | 4 studies | 53% ± 21% | |
GABAergic interneuron | 3 studies | 32% ± 12% | |
astrocyte | 3 studies | 37% ± 15% | |
rod bipolar cell | 3 studies | 34% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 94% | 4122.38 | 2475 / 2642 | 91% | 13.24 | 641 / 705 |
prostate | 64% | 881.76 | 156 / 245 | 44% | 0.83 | 219 / 502 |
uterus | 94% | 2796.42 | 159 / 170 | 10% | 0.46 | 44 / 459 |
adipose | 92% | 1996.68 | 1105 / 1204 | 0% | 0 | 0 / 0 |
breast | 72% | 1427.25 | 331 / 459 | 15% | 0.51 | 172 / 1118 |
adrenal gland | 10% | 86.57 | 25 / 258 | 77% | 9.49 | 176 / 230 |
muscle | 85% | 2116.30 | 682 / 803 | 0% | 0 | 0 / 0 |
liver | 50% | 637.52 | 114 / 226 | 32% | 1.27 | 130 / 406 |
esophagus | 71% | 3606.55 | 1019 / 1445 | 9% | 0.29 | 16 / 183 |
intestine | 72% | 2106.76 | 695 / 966 | 3% | 0.08 | 16 / 527 |
bladder | 67% | 1891.19 | 14 / 21 | 2% | 0.05 | 12 / 504 |
stomach | 40% | 1734.74 | 145 / 359 | 8% | 0.25 | 22 / 286 |
blood vessel | 36% | 369.70 | 482 / 1335 | 0% | 0 | 0 / 0 |
ovary | 11% | 112.48 | 19 / 180 | 19% | 0.55 | 82 / 430 |
kidney | 3% | 17.26 | 3 / 89 | 25% | 0.68 | 227 / 901 |
heart | 19% | 143.57 | 162 / 861 | 0% | 0 | 0 / 0 |
spleen | 19% | 124.41 | 45 / 241 | 0% | 0 | 0 / 0 |
lung | 11% | 74.51 | 62 / 578 | 5% | 0.14 | 62 / 1155 |
skin | 12% | 97.60 | 215 / 1809 | 2% | 0.05 | 8 / 472 |
pancreas | 0% | 1.62 | 1 / 328 | 13% | 0.55 | 23 / 178 |
eye | 0% | 0 | 0 / 0 | 6% | 0.76 | 5 / 80 |
peripheral blood | 5% | 29.37 | 45 / 929 | 0% | 0 | 0 / 0 |
thymus | 2% | 15.86 | 14 / 653 | 2% | 0.08 | 11 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_2000671 | Biological process | regulation of motor neuron apoptotic process |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0045163 | Biological process | clustering of voltage-gated potassium channels |
GO_0048678 | Biological process | response to axon injury |
GO_0098900 | Biological process | regulation of action potential |
GO_1900454 | Biological process | positive regulation of long-term synaptic depression |
GO_0046676 | Biological process | negative regulation of insulin secretion |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0006904 | Biological process | vesicle docking involved in exocytosis |
GO_0097623 | Biological process | potassium ion export across plasma membrane |
GO_0010701 | Biological process | positive regulation of norepinephrine secretion |
GO_0045956 | Biological process | positive regulation of calcium ion-dependent exocytosis |
GO_0090314 | Biological process | positive regulation of protein targeting to membrane |
GO_0033605 | Biological process | positive regulation of catecholamine secretion |
GO_0001508 | Biological process | action potential |
GO_0007215 | Biological process | glutamate receptor signaling pathway |
GO_1902065 | Biological process | response to L-glutamate |
GO_0042593 | Biological process | glucose homeostasis |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0043204 | Cellular component | perikaryon |
GO_0042383 | Cellular component | sarcolemma |
GO_0032809 | Cellular component | neuronal cell body membrane |
GO_1990635 | Cellular component | proximal dendrite |
GO_0030425 | Cellular component | dendrite |
GO_0098981 | Cellular component | cholinergic synapse |
GO_0009986 | Cellular component | cell surface |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0030424 | Cellular component | axon |
GO_0099634 | Cellular component | postsynaptic specialization membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0032590 | Cellular component | dendrite membrane |
GO_0015271 | Molecular function | outward rectifier potassium channel activity |
GO_0005251 | Molecular function | delayed rectifier potassium channel activity |
GO_0000149 | Molecular function | SNARE binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KCNB1 |
Protein name | Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1) Potassium voltage-gated channel subfamily B member 1 Potassium voltage-gated channel subfamily B member 1 (Voltage-gated potassium channel subunit Kv2.1) |
Synonyms | |
Description | FUNCTION: Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain, but also in the pancreas and cardiovascular system. Contributes to the regulation of the action potential (AP) repolarization, duration and frequency of repetitive AP firing in neurons, muscle cells and endocrine cells and plays a role in homeostatic attenuation of electrical excitability throughout the brain . Plays also a role in the regulation of exocytosis independently of its electrical function (By similarity). Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane. Homotetrameric channels mediate a delayed-rectifier voltage-dependent outward potassium current that display rapid activation and slow inactivation in response to membrane depolarization . Can form functional homotetrameric and heterotetrameric channels that contain variable proportions of KCNB2; channel properties depend on the type of alpha subunits that are part of the channel (By similarity). Can also form functional heterotetrameric channels with other alpha subunits that are non-conducting when expressed alone, such as KCNF1, KCNG1, KCNG3, KCNG4, KCNH1, KCNH2, KCNS1, KCNS2, KCNS3 and KCNV1, creating a functionally diverse range of channel complexes . Heterotetrameric channel activity formed with KCNS3 show increased current amplitude with the threshold for action potential activation shifted towards more negative values in hypoxic-treated pulmonary artery smooth muscle cells (By similarity). Channel properties are also modulated by cytoplasmic ancillary beta subunits such as AMIGO1, KCNE1, KCNE2 and KCNE3, slowing activation and inactivation rate of the delayed rectifier potassium channels (By similarity). In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Major contributor to the slowly inactivating delayed-rectifier voltage-gated potassium current in neurons of the central nervous system, sympathetic ganglion neurons, neuroendocrine cells, pancreatic beta cells, cardiomyocytes and smooth muscle cells. Mediates the major part of the somatodendritic delayed-rectifier potassium current in hippocampal and cortical pyramidal neurons and sympathetic superior cervical ganglion (CGC) neurons that acts to slow down periods of firing, especially during high frequency stimulation. Plays a role in the induction of long-term potentiation (LTP) of neuron excitability in the CA3 layer of the hippocampus (By similarity). Contributes to the regulation of glucose-induced action potential amplitude and duration in pancreatic beta cells, hence limiting calcium influx and insulin secretion . Plays a role in the regulation of resting membrane potential and contraction in hypoxia-treated pulmonary artery smooth muscle cells. May contribute to the regulation of the duration of both the action potential of cardiomyocytes and the heart ventricular repolarization QT interval. Contributes to the pronounced pro-apoptotic potassium current surge during neuronal apoptotic cell death in response to oxidative injury. May confer neuroprotection in response to hypoxia/ischemic insults by suppressing pyramidal neurons hyperexcitability in hippocampal and cortical regions (By similarity). Promotes trafficking of KCNG3, KCNH1 and KCNH2 to the cell surface membrane, presumably by forming heterotetrameric channels with these subunits . Plays a role in the calcium-dependent recruitment and release of fusion-competent vesicles from the soma of neurons, neuroendocrine and glucose-induced pancreatic beta cells by binding key components of the fusion machinery in a pore-independent manner (By similarity). . |
Accessions | A0A1B0GTM8 ENST00000635465.1 Q2NLD5 ENST00000635878.1 ENST00000371741.6 Q14721 ENST00000637131.1 A0A1B0GU02 |